Join over 200 gastroenterology experts at the 'Gastrocon' national conference in Ranchi from October 5-6, focusing on cutting-edge treatments for stomach, liver, and intestinal diseases.

Triveni Bio Inc. has brought in a $115 million Series B financing led by Goldman Sachs Alternatives. The Watertown company ...

This article will explore what pancreatitis is, both acute and chronic. Discover what sets off this condition, it telltale signs and the diverse approaches to treatment, including medical procedures, ...

Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...